These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8899842)

  • 1. Predicting injection site muscle damage. I: Evaluation of immediate release parenteral formulations in animal models.
    Sutton SC; Evans LA; Rinaldi MT; Norton KA
    Pharm Res; 1996 Oct; 13(10):1507-13. PubMed ID: 8899842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting injection site muscle damage. II: Evaluation of extended release parenteral formulations in animal models.
    Sutton SC; Evans LA; Rinaldi MT; Norton KA
    Pharm Res; 1996 Oct; 13(10):1514-8. PubMed ID: 8899843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting injection site muscle damage. III: Evaluation of intramuscular formulations in the L6 cell model.
    Evans LA; Genereux PE; Gibbs EM; Sutton SC
    Pharm Res; 1996 Oct; 13(10):1585-7. PubMed ID: 8899856
    [No Abstract]   [Full Text] [Related]  

  • 4. Rat paw-lick/muscle irritation model for evaluating parenteral formulations for pain-on-injection and muscle damage.
    Chellman GJ; Faurot GF; Lollini LO; McCullough TE
    Fundam Appl Toxicol; 1990 Nov; 15(4):697-709. PubMed ID: 2086314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pain and irritation following local administration of parenteral formulations using the rat paw lick model.
    Gupta PK; Patel JP; Hahn KR
    J Pharm Sci Technol; 1994; 48(3):159-66. PubMed ID: 8069518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release.
    Lefebvre HP; Laroute V; Braun JP; Lassourd V; Toutain PL
    Vet Res; 1996; 27(4-5):343-61. PubMed ID: 8822606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local tissue damage after intramuscular injections in rabbits and pigs: quantitation by determination of creatine kinase activity at injection sites.
    Diness V
    Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):410-5. PubMed ID: 4036633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tests for local toxicity of intramuscular drug preparations: comparison of in vivo and in vitro methods.
    Svendsen O; Højelse F; Bagdon RE
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):183-90. PubMed ID: 3993387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity [proceedings].
    Svendsen O; Rasmussen F; Nielsen P; Steiness E
    Arch Toxicol Suppl; 1979; (2):409. PubMed ID: 288353
    [No Abstract]   [Full Text] [Related]  

  • 10. Appraisal of the intramuscular irritation test in the rabbit.
    Gray JE
    Fundam Appl Toxicol; 1981; 1(3):290-2. PubMed ID: 7184795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and residues in milk of oxytetracyclines administered parenterally to dairy goats.
    Rule R; Moreno L; Serrano JM; Roman AG; Moyano R; Garcia J
    Aust Vet J; 2001 Jul; 79(7):492-6. PubMed ID: 11549049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain on injection and muscle irritation: a comparison of animal models for assessing parenteral antibiotics.
    Comereski CR; Williams PD; Bregman CL; Hottendorf GH
    Fundam Appl Toxicol; 1986 Feb; 6(2):335-8. PubMed ID: 3699322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro model to evaluate muscle damage following intramuscular injections.
    Brazeau GA; Fung HL
    Pharm Res; 1989 Feb; 6(2):167-70. PubMed ID: 2762216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity.
    Svendsen O; Rasmussen F; Nielsen P; Steiness E
    Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):324-8. PubMed ID: 474142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioavailability of muscle creatine kinase in sheep. Application to the assessment of local tolerance to injectable veterinary formulations].
    Verlinde V; Mikaelian I; Laurentie M; Sanders P; Poul JM
    Vet Res; 1996; 27(2):133-46. PubMed ID: 8721293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle toxicity of diatrizoate and iohexol in rabbits. A model for local tissue damage.
    Thomsen HS; Golman K; Svendsen O
    Acta Radiol; 1991 Mar; 32(2):182-3. PubMed ID: 2031807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs.
    Steiness E; Rasmussen F; Svendsen O; Nielsen P
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):357-64. PubMed ID: 581031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo non-invasive quantification of muscle damage following a single intramuscular injection of phenylbutazone in sheep.
    Houpert P; Serthelon JP; Lefebvre HP; Toutain PL; Braun JP
    Vet Hum Toxicol; 1995 Apr; 37(2):105-10. PubMed ID: 7631487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue tolerance of intramuscular injectables and plasma enzyme activities in rats.
    Surber C; Sucker H
    Pharm Res; 1987 Dec; 4(6):490-4. PubMed ID: 3508562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A test for muscle lesions and their regeneration following intramuscular drug application.
    Grim M; Rerábková L; Carlson BM
    Toxicol Pathol; 1988; 16(4):432-42. PubMed ID: 3222624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.